Clinical trials
Lung Diseases, Interstitial trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
120 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 9 |
| 2017 | 3 |
| 2018 | 9 |
| 2019 | 16 |
| 2020 | 15 |
| 2021 | 12 |
| 2022 | 11 |
| 2023 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 120 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 5 |
| Guangzhou Institute of Respiratory Disease | 5 |
| Hospices Civils de Lyon | 3 |
| Pulmonary Care and Research Collaborative Limited | 3 |
| Sheba Medical Center | 3 |
| University of Zurich | 3 |
| Central Hospital, Nancy, France | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Hospital do Coracao | 2 |
| Laval University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 120 |
| Pulmonary Disease, Chronic Obstructive | 19 |
| Idiopathic Pulmonary Fibrosis | 15 |
| Pulmonary Fibrosis | 15 |
| Arthritis, Rheumatoid | 12 |
| COVID-19 | 7 |
| Connective Tissue Diseases | 6 |
| Sarcoidosis | 6 |
| Scleroderma, Systemic | 6 |
| Dyspnea | 5 |
Trials
Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.
20 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.